The Neuroendocrine Tumor Research Foundation (NETRF) announced in January 2024 its newest neuroendocrine tumor (NET) research grant recipients. The eleven investigators receiving awards are studying the most promising scientific approaches to understanding and treating NETs. Funding for these eleven grants totals $1.91 million.
“We are excited to provide essential funding to these talented scientists and their innovative projects to advance the search for cures for neuroendocrine cancer,” said Elyse Gellerman, NETRF’s chief executive officer. “We fund researchers who are committed to unraveling the mysteries of NETs because this is how we will make progress against this disease,” she said.
As the leading global funder of NET research, NETRF funds two and a half times more NET investigators than the National Institutes of Health. More often than not, NETRF is the only funding resource available to scientists who want to dedicate their research to this complicated and uncommon cancer.
